While preliminary research into the anti‐tumor mechanism of SH in HCC has focused on its role in inhibiting LIF expression, it has not been definitively established that SH directly targets LIF, rendering it an LIF modulator instead of an LIF inhibitor. This evidence concerns the gene LIF and neoplasm.